Lance E Thibault - Net Worth and Insider Trading

Lance E Thibault Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lance E Thibault owns 7 companies in total, including Pieris Pharmaceuticals Inc (PIRS) , Proteostasis Therapeutics Inc (PTI) , and Aadi Bioscience Inc (AADI) among others .

Click here to see the complete history of Lance E Thibault’s form 4 insider trades.

Insider Ownership Summary of Lance E Thibault

Ticker	Comapny	Transaction Date	Type of Owner
PIRS	Pieris Pharmaceuticals Inc	2017-02-02	Acting Chief Financial Officer
PTI	Proteostasis Therapeutics Inc	2016-02-10	See Remarks
AADI	Aadi Bioscience Inc	2021-08-26	Chief Financial Officer
		2016-02-10	See Remarks
		2022-02-03	See Remarks
		2016-02-10	See Remarks
		2023-05-16	Chief Financial Officer

Lance E Thibault Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Lance E Thibault Ownership Network

Ownership Network List of Lance E Thibault

No Data

Ownership Network Relation of Lance E Thibault

Lance E Thibault Owned Company Details

What does Pieris Pharmaceuticals Inc do?

Who are the key executives at Pieris Pharmaceuticals Inc?

Lance E Thibault is the Acting Chief Financial Officer of Pieris Pharmaceuticals Inc. Other key executives at Pieris Pharmaceuticals Inc include 10 percent owner Bvf Gp Holdings Llc , other: See Explanation of Responses Bvf Ii Gp Llc , and 10 percent owner Bvf I Gp Llc .

Pieris Pharmaceuticals Inc (PIRS) Insider Trades Summary

Over the past 18 months, Lance E Thibault made no insider transaction in Pieris Pharmaceuticals Inc (PIRS). Other recent insider transactions involving Pieris Pharmaceuticals Inc (PIRS) include a net purchase of 6,000 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of Pieris Pharmaceuticals Inc (PIRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pieris Pharmaceuticals Inc (PIRS) were sold and 6,000 shares were bought by its insiders, resulting in a net purchase of 6,000 shares.

Pieris Pharmaceuticals Inc (PIRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pieris Pharmaceuticals Inc Insider Transactions

No Available Data

What does Proteostasis Therapeutics Inc do?

Who are the key executives at Proteostasis Therapeutics Inc?

Lance E Thibault is the See Remarks of Proteostasis Therapeutics Inc. Other key executives at Proteostasis Therapeutics Inc include Interim Head of Finance Michael Alfieri , director & President and CEO Meenu Chhabra , and See Remarks Eric D Larson .

Proteostasis Therapeutics Inc (PTI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Proteostasis Therapeutics Inc (PTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Proteostasis Therapeutics Inc (PTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Proteostasis Therapeutics Inc (PTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Proteostasis Therapeutics Inc Insider Transactions

No Available Data

What does Aadi Bioscience Inc do?

Who are the key executives at Aadi Bioscience Inc?

Lance E Thibault is the Chief Financial Officer of Aadi Bioscience Inc. Other key executives at Aadi Bioscience Inc include director & Chief Executive Officer David James Lennon , director & See Remarks Neil Desai , and Chief Financial Officer Scott M. Giacobello .

Aadi Bioscience Inc (AADI) Insider Trades Summary

Over the past 18 months, Lance E Thibault made no insider transaction in Aadi Bioscience Inc (AADI). Other recent insider transactions involving Aadi Bioscience Inc (AADI) include a net sale of 660,000 shares made by Neil Desai , and a net sale of 9,689 shares made by David James Lennon .

In summary, during the past 3 months, insiders sold 49,689 shares of Aadi Bioscience Inc (AADI) in total and bought 0 shares, with a net sale of 49,689 shares. During the past 18 months, 669,689 shares of Aadi Bioscience Inc (AADI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 669,689 shares.

Aadi Bioscience Inc (AADI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aadi Bioscience Inc Insider Transactions

No Available Data

What does Yumanity Therapeutics Inc do?

Who are the key executives at Yumanity Therapeutics Inc?

Lance E Thibault is the See Remarks of Yumanity Therapeutics Inc. Other key executives at Yumanity Therapeutics Inc include director & Chief Executive Officer Shawn Iadonato , President Craig W. Philips , and General Counsel Pauline Kenny .

Yumanity Therapeutics Inc (YMTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Yumanity Therapeutics Inc Insider Transactions

No Available Data

What does Arcellx Inc do?

Who are the key executives at Arcellx Inc?

Lance E Thibault is the See Remarks of Arcellx Inc. Other key executives at Arcellx Inc include Chief Financial Officer Michelle Gilson , Chief Medical Officer Christopher Heery , and director & See Remarks Rami Elghandour .

Arcellx Inc (ACLX) Insider Trades Summary

Over the past 18 months, Lance E Thibault made no insider transaction in Arcellx Inc (ACLX). Other recent insider transactions involving Arcellx Inc (ACLX) include a net sale of 343,050 shares made by Christopher Heery , a net sale of 77,979 shares made by Kavita Patel , and a net sale of 69,452 shares made by Michelle Gilson .

In summary, during the past 3 months, insiders sold 123,466 shares of Arcellx Inc (ACLX) in total and bought 0 shares, with a net sale of 123,466 shares. During the past 18 months, 1,950,953 shares of Arcellx Inc (ACLX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,950,953 shares.

Arcellx Inc (ACLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arcellx Inc Insider Transactions

No Available Data

What does Kineta Inc do?

Who are the key executives at Kineta Inc?

Lance E Thibault is the See Remarks of Kineta Inc. Other key executives at Kineta Inc include director & Chief Executive Officer Shawn Iadonato , President Craig W. Philips , and General Counsel Pauline Kenny .

Kineta Inc (KANT) Insider Trades Summary

Over the past 18 months, Lance E Thibault made no insider transaction in Kineta Inc (KANT). Other recent insider transactions involving Kineta Inc (KANT) include a net purchase of 7,250 shares made by Raymond J. Bartoszek , a net purchase of 15,000 shares made by Shawn Iadonato , and a net purchase of 10,000 shares made by Keith Baker .

In summary, during the past 3 months, insiders sold 0 shares of Kineta Inc (KANT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kineta Inc (KANT) were sold and 50,250 shares were bought by its insiders, resulting in a net purchase of 50,250 shares.

Kineta Inc (KANT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kineta Inc Insider Transactions

No Available Data

What does Finch Therapeutics Group Inc do?

Who are the key executives at Finch Therapeutics Group Inc?

Lance E Thibault is the Chief Financial Officer of Finch Therapeutics Group Inc. Other key executives at Finch Therapeutics Group Inc include Chief Executive Officer Matthew P. Blischak , Chief Business & Legal Officer Joseph Vittiglio , and Chief Operating Officer Marc Blaustein .

Finch Therapeutics Group Inc (FNCH) Insider Trades Summary

Over the past 18 months, Lance E Thibault made no insider transaction in Finch Therapeutics Group Inc (FNCH). Other recent insider transactions involving Finch Therapeutics Group Inc (FNCH) include a net sale of 9,712 shares made by Jeffery A Smisek , and a net purchase of 5,010 shares made by Susan E Graf .

In summary, during the past 3 months, insiders sold 0 shares of Finch Therapeutics Group Inc (FNCH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,712 shares of Finch Therapeutics Group Inc (FNCH) were sold and 167 shares were bought by its insiders, resulting in a net sale of 9,545 shares.

Finch Therapeutics Group Inc (FNCH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Finch Therapeutics Group Inc Insider Transactions

No Available Data

Lance E Thibault Mailing Address

Above is the net worth, insider trading, and ownership report for Lance E Thibault. Currently GuruFocus does not have mailing address information for Lance E Thibault.

Discussions on Lance E Thibault

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.